Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations · Executive or director change
  3. 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 4,928 shares at $2.67 ($13,158)
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. 144 Insider Sale of Securities
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 8-K Event Shareholder vote results
  12. 4 Planned sale SVP, Chief Financial Officer sold 464 shares at $2.70 ($1,253)
  13. 4 Planned sale CEO sold 15,380 shares at $2.70 ($41,543)
  14. 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 731 shares at $2.70 ($1,975)
  15. SCHEDULE 13G Stake Statement of Beneficial Ownership
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. 144 Insider Sale of Securities
  19. 424B5 Offering Prospectus
  20. 8-K Event Material agreement · Other events

Page 2 of 37 · 731 filings